WHO Executive Board meets in the shadow of second Trump withdrawal
PHM's item commentaries for EB156 (selected items) are now posted.
Webinar: Challenging the idea of “substandard and falsified medical products”: what role for WHO in facilitating geographically diversified medical manufacturing?
Join us on Tuesday 21 January 2025, from 15.00 to 16.30 for our fourth session of the G2H2 Policy Debates i
Public Pharma for Europe: The Case of CAR-T Cell Therapy
On far too many occasions, publicly funded medical research that leads to successful health technologies fa
Who gets to define the future? The UN’s summit as a mechanism for corporate capture
The world is facing an unprecedented convergence of crises—climate change, pandemics, natural disasters, ge
Webinar: Critical Questions Ahead of INB 11: Shaping a Fair Pandemic Agreement
On September 9, the textual negotiations for a Pandemic Agreement will finally resume, amidst heightened pr
What is happening at the 77th World Health Assembly- 2024? And an Introduction to the WHO Tracker
By Dr. T. Sundararaman and David Legge
PHM at 77th World Health Assembly, May 2024
This May 2024 PHM gathers in Geneva to attend the WHO Watch, a PHM programme which closely follows the two
WHA77 Document and Commentary Tracker
Keep track of the discussions, documents, commentaries and the agenda of the 77th World Health Assembly WHA
PHM Pandemic Treaty Workshop
The PHM Global Health Governance group would like to invite you to a workshop on the latest Pandemic Treaty